Drugs / EV-Pure™
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05387278 | Mar → Oct 2025 | acute respiratory distress syndrome | Vitti Labs, LLC | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EV-Pure | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05387278 ↗ |
| Route | Intravenous | “intravenous infusion of a mixture of EV-Pure™ and WJ-Pure™” NCT05387278 ↗ |